Option Care Health 하루 +33% 급등 — 58억 달러 인수전, 주주에겐 충분한 가격일까

안녕하세요, 30대 진도리입니다. 매주 월~토 오전 9시, AI로 분석해보는 해외주식 트렌드 리포트입니다. 어제(10월 6일) 미국 증시에서 가장 눈에 띈 움직임은 홈 인퓨전(가정 수액·주사 치료) 1위 기업 Option Care Health(OPCH) 였습니다. 맥케슨(McKesson)과 사모펀드 CD&R이 약 58억 달러에 인수하겠다고 발표하면서 주가가 하루 만에 30% 넘게 뛰었습니다. 본 글은 정보 제공·관찰용 이며, 매수·매도 권유가 아닙니다. 저는 현재 OPCH를 모니터링 중 이며, 직접 보유하고 있지 않습니다. 환율은 편의상 1 USD = 1,400 KRW 로 계산했고, 수치는 2026-10-06~07 보도 기준입니다. 📌 한 줄 요약 이슈: McKesson·CD&R이 OPCH를 주당 $32.05 현금 (약 44,870원), 기업가치 약 58억 달러(8.1조 원) 에 인수 합의 (10/6 발표). 왜 중요한가: 인수가는 10/5 종가 대비 약 37% 프리미엄 . CD&R 51% · McKesson 49%(약 14억 달러 투자) 구조에 McKesson이 나중에 지분을 넘겨받을 ‘옵션 틀’까지 포함. 시장 반응: 주가 약 +32.7% → $31.00 . 인수가보다 약 3% 낮은 가격에서 거래 — 시장은 ‘성사 가능성 높다’고 보는 모습. 다음 이벤트: 11월 4일 3분기 실적(컨퍼런스콜 없음) · 주주 승인 · 2027년 상반기 클로징 목표. 주요 리스크: ① 규제 승인 ② 경쟁 입찰 가능성(프리미엄 ‘아쉽다’는 시각) ③ 딜 무산 시 올해 부진했던 펀더멘털로 회귀. 🎯 Option Care Health 하루 +33% 급등 — 58억 달러 인수전, 주주에겐 충분한 가격일까 Option Care Health(NASDAQ: OPCH)는 미국 ...
댓글 쓰기

UNH Stock Collapse 2025: Buying Opportunity or Breakdown?

📌 Key Takeaways

  • UNH dropped -52% due to leadership vacuum and DOJ investigation
  • Fundamentals remain strong with defensive stock characteristics
  • Rather than short-term rebound, consider phased buying after leadership stabilization
📌 AI Disclosure
This article was prepared using ChatGPT's summarization capabilities and includes the author's interpretation and opinion.
All charts and scores are based on publicly available data and should be considered as subjective reference materials. This is not investment advice.
📌 About This Report
This post was written using ChatGPT's data summarization capabilities, incorporating public financial information and the author’s own interpretation. The graphs and scores presented are for reference only and do not constitute investment advice.

🩺 UnitedHealth (UNH) — Collapse of a Leader or Buying Opportunity?

✍️ Author’s Perspective

UNH has long symbolized strength in the healthcare sector, known for its AI-powered medical efficiency tools and data dominance through Optum Insight. However, recent events—including DOJ investigations and leadership turmoil—have shaken that image.

UNH’s sudden drop not only shocked the market, it raised the question: is this a breakdown or a rare value opportunity? Let’s break down the fundamental value, risks, and strategic considerations for investors.

📌 Case Summary: Healthcare Giant Shaken

On May 21, 2025, UnitedHealth Group (UNH) plunged 5.8% in a single session, closing at $302.98. For the largest health insurer and medical service provider in the U.S., it was a trust-shaking event driven by several headlines:

  • DOJ Investigation: Incentives offered to nursing homes to reduce hospital transfers
  • CEO Replacement: Andrew Witty out, Stephen Hemsley returns
  • 2025 Earnings Guidance Withdrawn
  • HSBC Downgrade: Target cut from $490 → $270, rating downgraded to ‘Sell’

📉 52-week range: High of $630.73 → Current $302.98 (-52%)

🔍 Is This a Bottom or a Trap?

📉 Short-Term View

  • Price crash + 3x volume surge: panic selling, possible early-stage rotation
  • Legal uncertainty + weak leadership visibility: technical rebound may be unstable

🧭 Strategy Matrix

Strategy Trigger Explanation
❌ Sell Break below $300 + prolonged investigation Confidence may take time to recover
⏸️ Watch Support at $280 holds Wait for confirmation of technical rebound
✅ Accumulate Leadership stabilization + investigation resolution Long-term opportunity for value investors

💡 UNH’s Long-Term Fundamental Strengths

🏥 1. Integrated Business Structure & Market Power

  • Vertical integration: UnitedHealthcare (insurance) + Optum (services)
  • 52 million insured members, dominant PBM market share

💵 2. Cash Flow & Dividend Stability

  • Free cash flow over $23B (2024)
  • 10+ years of dividend growth, current yield 1.5%

🧠 3. AI-Driven Medical Efficiency

  • AI-powered EMR analytics centered on Optum Insight

🌎 4. Beneficiary of Aging Demographics

📊 Stock Chart Analysis

Daily Chart

Daily Chart

Monthly Chart

Monthly Chart

Yearly Chart

Yearly Chart

📊 Fundamental Indicator Summary (2025)

Metric Score (out of 100) Interpretation
PER 60 Entered undervalued range post sharp price drop
PBR 50 Still trading at low value relative to assets
EPS Growth 55 Recovering post guidance withdrawal
ROE 88 Consistently strong capital efficiency
Volume Change 95 Unusual spike suggests bottom rotation potential
Dividend Yield 72 Stable payout, attractive for long-term holders

📈 Radar Chart Analysis

Radar Chart

📉 Absolute vs Relative Valuation

Valuation Chart

※ This chart compares UNH’s absolute financial indicators to industry averages and competitors. Data includes stock price levels, PER, and dividend yield.

📊 Peer Comparison (Cigna, Elevance, UNH)

Metric UnitedHealth (UNH) Elevance Health Cigna Group
Market Cap $280B 12B $86B
PER 15.3x 12.7x 11.5x
ROE 17.2% 15.4% 13.8%
EPS Growth 5.1% 6.5% 8.2%
Dividend Yield 1.5% 1.3% 1.4%

🔼🔽 UNH Strengths & Weaknesses

Strengths Weaknesses
Dominant market share through insurance + services integration Ongoing regulatory and legal risks
Stable dividend policy with strong cash flow Valuation concerns (still above industry PER)
Beneficiary of aging demographic trends Slower growth potential vs competitors
AI-powered healthcare analytics via Optum Insight —

📈 Financial Score Summary

🔗 Related Content

⚠️ Investment Disclaimer

This article is for informational purposes only and does not constitute financial advice. All opinions are personal and based on publicly available data and AI-assisted analysis. Please make investment decisions at your own risk.

📚 Sources & References